3rd Value Added Medicines Conference, Brussels - Main contents
| date | November 21, 2019 |
|---|---|
| city | Brussels, Belgium |
| organisation | Medicines for Europe |
REGISTER NOW
Please book as soon as possible to benefit from the conference rate of 209 Euro
per night (this rate is subject to availability!)
ADVERTISING, EXHIBITION & SPONSORSHIP OPPORTUNITIES
Contents
Would you like to know more?
Join us at the 3rd Value Added Medicines Conference
on 21st November 2019 in Brussels!
Our population is ageing. We are living and working longer, opening the possibilities for specific ‘silver’ needs, namely in healthcare where chronic diseases are becoming more prevalent.
Value added medicines can provide new solutions for patients, healthcare professionals and healthcare systems in this new era by improving patient adherence, quality of life and other health outcomes, as well as by tackling healthcare system inefficiencies, healthcare provision and organisation.
During the conference, you will learn how to create an optimal environment to enable elderly people to benefit from value added medicines and the role of the various healthcare stakeholders in this process.
You will learn more about regulatory and legal topics, market access, the future outlook in the digital space of value added medicines and much more!
jQuery(document).ready(function($){ $("#team-8312 .team-items").owlCarousel({ items : 5, //10 items above 1000px browser width autoHeight:true, responsiveClass:true, responsive:{ 0:{ items:1, nav:true }, 600:{ items:2, nav:true }, 900:{ items:2, nav:true }, 1000:{ items:5, nav:true, } }, navText : ["",""], nav: true, }); });
Senior Vice President, Teva and President Medicines for Europe
Christoph StollerSenior Vice President, Teva and President Medicines for Europe
Albert Wertheimer, PhD, MBA, Professor
College of Pharmacy, Department of Sociobehavioral and Administrative Pharmacy, Nova Southeastern University
Albert Wertheimer, PhD, MBA, ProfessorCollege of Pharmacy, Department of Sociobehavioral and Administrative Pharmacy, Nova Southeastern University
Executive Editor, Informa
David WallaceExecutive Editor, Informa
Founder & CEO, Rejuvenate Biomed
Ann Beliën, PhD, PMPFounder & CEO, Rejuvenate Biomed
Head of the Medical Department and QQPV, EudraVigilance Representative, Tecnimede
Augusto Filipe, Dr. MDHead of the Medical Department and QQPV, EudraVigilance Representative, Tecnimede
Senior Registration Manager, Mylan
Geraldine MooreSenior Registration Manager, Mylan
Administrator, DG Health and Food Safety - European Commission
Helen LeeAdministrator, DG Health and Food Safety - European Commission
President and Founder, Camargo Pharmaceutical Services
Kenneth V. PhelpsPresident and Founder, Camargo Pharmaceutical Services
Chair in Technology & Innovation Management (Healthcare), Imperial College Bussiness School
Prof. Dr. James BarlowChair in Technology & Innovation Management (Healthcare), Imperial College Bussiness School
Business Development Department, Oyer Pharma
Maria Rúbies RoyoBusiness Development Department, Oyer Pharma
Executive Director, European Brain Council
Frédéric DestrebecqExecutive Director, European Brain Council
Prof. Dr. Jean Bousquet, MD, PhD
Honorary Professor of Pulmonary Medicine, University of Montpellier
Prof. Dr. Jean Bousquet, MD, PhDHonorary Professor of Pulmonary Medicine, University of Montpellier
Coordinator of Procedures, National Institute for Health and Disability Insurance, INAMI-RIZIV
Vinciane KnappenbergCoordinator of Procedures, National Institute for Health and Disability Insurance, INAMI-RIZIV
Business Development Director, Egis Pharmaceuticals PLC
Klára Marton MD, MBABusiness Development Director, Egis Pharmaceuticals PLC
Professor of Health Economics, Center for Health Technology Assessment, Semmelweis University
Prof. Dr. Zoltán KalóProfessor of Health Economics, Center for Health Technology Assessment, Semmelweis University
CEO, Pharmaphorum
Paul TunnahCEO, Pharmaphorum
General Partner, Healthware Labs
Gerry ChillèGeneral Partner, Healthware Labs
Engagement Manager, European Thought Leadership, IQVIA
Aurelio AriasEngagement Manager, European Thought Leadership, IQVIA
Pulmonologist and Global Medical Director, Teva Pharmaceuticals
Guilherme SafiotiPulmonologist and Global Medical Director, Teva Pharmaceuticals
Director, European Federation of Allergy and Airways Diseases Patients' Associations (EFA)
Susanna PalkonenDirector, European Federation of Allergy and Airways Diseases Patients' Associations (EFA)
UCIBIO/REQUIMTE, Faculty of Pharmacy of University of Porto, Portugal. Co-coordinator of the action group on Adherence to prescription and medical plans of EIP-AHA
Prof. Elísio CostaUCIBIO/REQUIMTE, Faculty of Pharmacy of University of Porto, Portugal. Co-coordinator of the action group on Adherence to prescription and medical plans of EIP-AHA
Head Global Portfolio Strategy and Head European Business Operations, Mylan and Chairman of the Value Added Medicines Sector Group, Medicines for Europe
Arun NarayanHead Global Portfolio Strategy and Head European Business Operations, Mylan and Chairman of the Value Added Medicines Sector Group, Medicines for Europe
Medicines for Europe is honored to be collaborating with the following partners to make this year’s conference
M: +44 (0) 7 562 87 68 73
For more information on advertising, exhibition and sponsorship packages:
M: +31 6 4119 0824
Media Requirements and Press Policy
For any other media enquiries:
P: +32 (0)2 239 2019